The prevalence of DS is 1:15,700 individuals, with around 75% of patients bearing a mutation in their SCN1A gene, which encodes the α1 subunit of the voltage gated sodium channel (NaV1.1; Wu et al., 2015). The gene discussed is SCN1A; the disease is Dravet syndrome.